Director/PDMR Shareholding

RNS Number : 7272E
Kromek Group PLC
20 July 2016
 

20 July 2016

 

Kromek Group plc

("Kromek" or the "Company")

 

Director/PDMR Shareholding

 

Kromek (AIM: KMK), a radiation detection technology company focusing on the medical, security and nuclear markets, announces that it has today received notification that Dr. Arnab Basu, Chief Executive Officer of the Company, today exercised options over 800,000 ordinary shares of 1 pence each in the Company ("Ordinary Shares") pursuant to the EMI share option scheme.

 

Following the purchase, Dr. Basu has an interest in 2,872,000 Ordinary Shares representing 1.89% of the entire current issued share capital of the Company.

 

 

Enquiries

 

Kromek Group plc


Arnab Basu, CEO

Derek Bulmer, CFO

+44 (0)1740 626 060



Cenkos Securities plc


Bobbie Hilliam (NOMAD)

Julian Morse (Sales)

+44 (0)20 7397 8900



Luther Pendragon Ltd


Harry Chathli, Claire Norbury, Alexis Gore

+44 (0)20 7618 9100

 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014. The information set out below is provided in accordance with the requirements of Article 19(3) of that Regulation.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Dr Arnab Basu

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Executive Officer

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Kromek Group plc

b)

 

LEI

 

 

N/a

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary Shares of 1p each

 

 

 

 

b)

 

Nature of the transaction

 

 

Exercise of options over Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

1.5p (exercise price)

 

800,000

 

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

 

 

 

800,000

 

 

1.5p (exercise price)

 

e)

 

Date of the transaction

 

 

20 July 2016

f)

 

Place of the transaction

 

 

N/a

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHAKKDKCBKKNOB

Companies

Kromek Group (KMK)
UK 100

Latest directors dealings